How it often looks
A funding round, an Innovation Box claim, or a first international hire can each quietly shape — or block — the exit that comes years later.
Novera supports biotech, biopharma and other innovative companies on the tax side of growth: entering the Netherlands, investment rounds, the Innovation Box, and exit. The structure has to work for the company and for its founders and shareholders. Our focus is primarily on Life sciences & health, with other innovative companies alongside it, like tech, software, clean tech and deeptech.
- Tax advice & compliance (Innovation Box, corporate income tax, structure, M&A)
- Valuations (rounds, options, IP-related value)
The structure has to work for the company and for its founders and shareholders.
Big 4 experience
Senior advice on investment rounds, the Innovation Box and exit, without the Big 4 structure.
International
Dutch and cross-border tax advice for companies and founders building from the Netherlands.
Typical moments
- An investment round, when the rights of new and existing shareholders need to be set.
- The company turning a profit: that is the moment to put the Innovation Box in place, not afterwards.
- Setting up an employee equity or participation plan.
- A transfer of IP.
- An exit, or an intended sale.
Our expertise for life sciences & innovation
Substantial experience and genuine connections across the life sciences sector, with partners who bring a Big 4 background — without the Big 4 setup. Beyond life sciences, we advise the full spread of innovative companies: deep tech, tech, software and more.
